SIS
ANIP icon

Sound Income Strategies’s ANI Pharmaceuticals ANIP Stock Holding History

Sound Income Strategies’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-133
Closed -$10.1K – 568
2026
Q1 		$10.1K Buy
133
+106
+393% +$8.27K ﹤0.01% 1496
2025
Q4 		$2.29K Buy
+27
New +$2.34K ﹤0.01% 2092

Other funds holding ANIP

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
RL
Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Sound Income Strategies's ANIP Position: Q2 2026 in Review

Sound Income Strategies sold out of ANI Pharmaceuticals (ANIP) in Q2 2026, closing a stake of 133 shares — an estimated $10.1K sold.

Sound Income Strategies first reported a position in ANIP in Q4 2025 and held it in 2 quarters. The position peaked at $10.1K in Q1 2026. 63 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Sound Income Strategies reported no remaining ANI Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 133 ANI Pharmaceuticals shares in Q2 2026, an estimated $10.1K.
  • Sound Income Strategies first reported a position in ANI Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Sound Income Strategies's ANI Pharmaceuticals position peaked at $10.1K in Q1 2026.
  • 63 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.